| APGEApogee Therapeutics, Inc. | 374,000 | $31.5M |
| VORVor Biopharma Inc. | 1,750,000 | $31.2M |
| ZURAZura Bio Ltd | 4,215,930 | $25.1M |
| AMLXAmylyx Pharmaceuticals, Inc. | 1,750,000 | $24.3M |
| IBRXImmunityBio, Inc. | 3,000,800 | $23.0M |
| NKTRNEKTAR THERAPEUTICS | 316,453 | $22.8M |
| SLGLSol-Gel Technologies Ltd. | 274,363 | $21.7M |
| ALMSALUMIS INC. | 856,061 | $18.9M |
| DRUGBRIGHT MINDS BIOSCIENCES INC. | 220,000 | $16.1M |
| ANNXAnnexon, Inc. | 2,500,000 | $13.8M |
| KALVKalVista Pharmaceuticals, Inc. | 675,000 | $13.6M |
| IMVTImmunovant, Inc. | 545,625 | $13.6M |
| JBIOJade Biosciences, Inc. | 964,462 | $13.6M |
| ZBIOZenas BioPharma, Inc. | 524,066 | $10.2M |
| NGNENeurogene Inc. | 500,000 | $10.1M |
| MLTXMoonLake Immunotherapeutics | 500,000 | $9.3M |
| CLYMClimb Bio, Inc. | 1,334,130 | $9.1M |
| ORKAOruka Therapeutics, Inc. | 183,330 | $9.0M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 1,200,000 | $8.7M |
| VERAVera Therapeutics, Inc. | 199,348 | $8.0M |
| EVMNEvommune, Inc. | 325,000 | $7.5M |
| LBRXLB PHARMACEUTICALS INC | 300,000 | $7.4M |
| CMPXCompass Therapeutics, Inc. | 1,350,000 | $7.1M |
| SCYXSCYNEXIS INC | 7,554,347 | $6.9M |
| PALIPALISADE BIO, INC. | 3,405,757 | $6.0M |
| CNTXContext Therapeutics Inc. | 2,238,496 | $5.9M |
| RLMDRELMADA THERAPEUTICS, INC. | 842,106 | $5.9M |
| SLNSilence Therapeutics Plc | 1,020,489 | $5.4M |
| UNCYUnicycive Therapeutics, Inc. | 796,558 | $5.2M |
| PMNProMIS Neurosciences Inc. | 371,402 | $4.7M |
| CGEMCullinan Therapeutics, Inc. | 300,000 | $4.3M |
| IMMXImmix Biopharma, Inc. | 350,000 | $3.2M |
| RZLTRezolute, Inc. | 951,809 | $2.9M |
| PHVSPharvaris N.V. | 82,800 | $2.3M |
| HUMAHumacyte Inc. | 3,750,000 | $2.3M |
| GALTGALECTIN THERAPEUTICS INC | 800,000 | $2.2M |
| AVTXAvalo Therapeutics, Inc. | 124,666 | $1.9M |
| ALKSAlkermes plc. | 50,000 | $1.8M |
| AVXLANAVEX LIFE SCIENCES CORP. | 521,300 | $1.6M |
| IRDOpus Genetics, Inc. | 324,340 | $1.5M |